The Office of the Vice Chancellor for Research is pleased to announce that Professor Peter Molnar of the Cooperative Institute for Research in Environmental Sciences and the Department of Geological Sciences has been selected as the 2014 Distinguished Research Lecturer.
The 105th Distinguished Research Lecture will be presented on Oct. 18 at 3 p.m. in the Cristol Chemistry 140 auditorium. The Distinguished Research Lectureship is the highest honor bestowed upon a faculty member by the Graduate School. Its purpose is to honor and recognize an entire body of creative work and research.
On May 22, Jet Propulsion Laboratory (JPL) Director Charles Elachi and his senior management team met with University of Colorado Boulder Chancellor Philip P. DiStefano and several other campus administrators to sign a memorandum of understanding to continue and broaden a rich tradition of collaboration on space and Earth-science efforts going back nearly 50 years. Located in Pasadena, Calif., JPL is a federally funded research and development facility managed by the California Institute of Technology for NASA.
The University of Colorado Law School brought together industry leaders, top practicing lawyers, and members of the judiciary to discuss some of the most important issues facing the legal profession today. The Gathering of the Bench and Bar Conference was held Sept. 19–21.
“I envisioned this conference as a way to not only provide educational opportunities, but also to help students and new graduates expand their professional network,” said Phil Weiser, dean of Colorado Law.
Among cancers, scientists have spent their entire research careers looking for cellular similarities that may lead to a single cure for many cancers –– the rare chance to have a single answer to a multifaceted problem. In 1997, scientists discovered a gene that they believed was the key to cellular immortality. Telomerase Reverse Transcriptase, or TERT, is a catalytic piece of telomerase, and while cellular immortality sounds like a good idea, it is actually how cancerous tumors grow and proliferate in cancer patients. In a recent paper published in Science, Tom Cech, director of the BioFrontiers Institute, worked with collaborators at CU's Anschutz Medical Campus to study mutations in bladder cancer that may lead to better treatments for many types of cancers.